港股異動 | 新秀麗(1910.HK)一度漲超20% 年度扭虧為盈 賺1430萬美元
格隆匯3月17日丨新秀麗(1910.HK)盤中大幅拉昇漲超20%,現報16港元,暫成交1.3億港元,總市值223億港元。公司昨晚公吿,2021年股東應占溢利1430萬美元,每股盈利0.01美元,不派息。而2020年度同期錄虧損12.78億美元。期內,銷售淨額20.21億美元,按年上升31.5%。此外,2021年毛利率由去年的46.0%上升至54.5%。毛利率上升是由於集團上調所銷售產品的價格,以緩和產品、貨運及關税成本上升。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.